Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 11, Pages 610
Publisher
MDPI AG
Online
2019-11-14
DOI
10.3390/pharmaceutics11110610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
- (2019) Sara Palchetti et al. Pharmaceutics
- Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds
- (2019) Griffin Pauli et al. Pharmaceutics
- Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
- (2018) Kate Butcher et al. BMC CANCER
- Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity
- (2018) Maricela Viola-Rhenals et al. CURRENT MEDICINAL CHEMISTRY
- Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo
- (2018) Lingli Zhou et al. PHARMACEUTICAL RESEARCH
- Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer
- (2017) Mohammad Najlah et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
- (2017) Zhipeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram
- (2016) Mandip Shergill et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A simple approach to predict the stability of phospholipid vesicles to nebulization without performing aerosolization studies
- (2016) Sneha Subramanian et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells
- (2016) Mohammad Najlah et al. JOURNAL OF LIPOSOME RESEARCH
- Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy
- (2016) Wantong Song et al. Nanomedicine-Nanotechnology Biology and Medicine
- Are PEGylated liposomes better than conventional liposomes? A special case for vincristine
- (2015) Xuling Wang et al. DRUG DELIVERY
- Proliposome powders prepared using a slurry method for the generation of beclometasone dipropionate liposomes
- (2015) Iftikhar Khan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells
- (2015) Patricia Erebi Tawari et al. Toxicology Research
- Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
- (2015) Peng Liu et al. Oncotarget
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram
- (2014) Nisrina Ramadhani et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Sterically stabilized liposomes as a potent carrier for shikonin
- (2014) K. N. Kontogiannopoulos et al. JOURNAL OF LIPOSOME RESEARCH
- A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization
- (2014) Mohammad Najlah et al. JOURNAL OF LIPOSOME RESEARCH
- Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
- (2013) P Liu et al. BRITISH JOURNAL OF CANCER
- Brucine-loaded liposomes composed of HSPC and DPPC at different ratios:in vitroandin vivoevaluation
- (2013) Jun Chen et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Enhanced Therapeutic Efficacy of iRGD-Conjugated Crosslinked Multilayer Liposomes for Drug Delivery
- (2013) Yarong Liu et al. Biomed Research International
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Liposomal paclitaxel formulations
- (2012) Štěpán Koudelka et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
- (2010) F. Wang et al. CURRENT MEDICINAL CHEMISTRY
- Lipid Vesicle Aggregation Induced by Cooling
- (2010) Frank Howard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge
- (2010) S. Dadashzadeh et al. JOURNAL OF CONTROLLED RELEASE
- Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
- (2009) Xiaoxia Guo et al. CANCER LETTERS
- Do molecularly targeted agents in oncology have reduced attrition rates?
- (2008) Ian Walker et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started